KCF-18

Immune Research only Animal studies

A synthetic peptide designed from the binding regions of cytokine receptors. It attaches to several inflammatory signals at once, including TNF-α and IL-6, and keeps them from reaching their receptors. In mice it reduced white blood cell infiltration and vascular inflammation.

Why people take it

What studies report

• Blocked TNF-alpha and IL-6 from reaching their receptors in cell studies
• Reduced white cell infiltration in a mouse peritonitis model

Worth knowing: Very early research; one group, no human data.

Status: Early cell and mouse research only.

Route

Subcutaneous injection, from reconstituted lyophilised powder

Available as

10 mg

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.